
Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person’s odds for heart attacks and strokes, and now more data from the same trial suggests that’s even true for very ill patients with heart failure. The finding also helps clear up a concern around the use of Wegovy in these… read on > read on >